IL144679A0 - Process for the preparation of pseudomonic acid a antibiotic by microbiological method - Google Patents

Process for the preparation of pseudomonic acid a antibiotic by microbiological method

Info

Publication number
IL144679A0
IL144679A0 IL14467900A IL14467900A IL144679A0 IL 144679 A0 IL144679 A0 IL 144679A0 IL 14467900 A IL14467900 A IL 14467900A IL 14467900 A IL14467900 A IL 14467900A IL 144679 A0 IL144679 A0 IL 144679A0
Authority
IL
Israel
Prior art keywords
antibiotic
preparation
pseudomonic acid
microbiological method
microbiological
Prior art date
Application number
IL14467900A
Other languages
English (en)
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of IL144679A0 publication Critical patent/IL144679A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/38—Pseudomonas

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL14467900A 1999-02-03 2000-02-03 Process for the preparation of pseudomonic acid a antibiotic by microbiological method IL144679A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11845799P 1999-02-03 1999-02-03
US13733499P 1999-06-03 1999-06-03
PCT/US2000/002880 WO2000046389A1 (en) 1999-02-03 2000-02-03 Process for the preparation of pseudomonic acid a antibiotic by microbiological method

Publications (1)

Publication Number Publication Date
IL144679A0 true IL144679A0 (en) 2002-06-30

Family

ID=26816383

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14467900A IL144679A0 (en) 1999-02-03 2000-02-03 Process for the preparation of pseudomonic acid a antibiotic by microbiological method
IL144679A IL144679A (en) 1999-02-03 2001-08-01 Microbiological process for the preparation of pseudomonic acid antibiotic A

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL144679A IL144679A (en) 1999-02-03 2001-08-01 Microbiological process for the preparation of pseudomonic acid antibiotic A

Country Status (22)

Country Link
US (3) US6509177B1 (xx)
EP (1) EP1151131A4 (xx)
JP (1) JP2003515311A (xx)
KR (1) KR20010113674A (xx)
CN (2) CN1203184C (xx)
AU (1) AU762768B2 (xx)
BG (1) BG105776A (xx)
BR (1) BR0009179A (xx)
CA (1) CA2360865A1 (xx)
CZ (1) CZ20012724A3 (xx)
HK (1) HK1041903A1 (xx)
HR (1) HRP20010576A2 (xx)
HU (1) HUP0300363A2 (xx)
IL (2) IL144679A0 (xx)
IS (1) IS6028A (xx)
MX (1) MXPA01007806A (xx)
NO (1) NO20013791L (xx)
PL (1) PL358615A1 (xx)
SK (1) SK10892001A3 (xx)
TR (1) TR200102234T2 (xx)
WO (1) WO2000046389A1 (xx)
YU (1) YU55601A (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20012724A3 (cs) 1999-02-03 2001-12-12 Biogal Gyogyszergyar Rt Způsob přípravy antibiotické pseudomonové kyseliny A mikrobiologickou cestou
PL374255A1 (en) 2001-06-21 2005-10-03 Biogal Gyogyszergyar Rt Metabolic controlled fermentation process for pseudomonic acid production
HUP0600679A2 (en) 2001-12-28 2008-06-30 Biogal Gyogyszergyar Processes for preparing crystalline and amorphous mupirocin calcium and pharmaceutical compositions containing the same
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
ES2339682T3 (es) 2004-06-01 2010-05-24 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Procedimiento para la preparacion de la forma amorfa de un farmaco.
US7619102B2 (en) 2005-02-21 2009-11-17 Axellia Pharmaceuticals Aps Purification of mupirocin
WO2009117310A2 (en) * 2008-03-17 2009-09-24 Cedars-Sinai Medical Center Methods for treatment and prevention of mrsa/mssa
CN104370896A (zh) * 2013-11-29 2015-02-25 江苏汉邦科技有限公司 一种纯化假单孢菌素的方法
CN103820369B (zh) * 2014-03-07 2015-11-18 浙江瑞邦药业有限公司 一种萤光假单胞菌及其应用
CN108277243B (zh) * 2018-01-19 2021-03-12 浙江瑞邦药业股份有限公司 一种假单胞菌酸a的制备方法
CN108949845B (zh) * 2018-08-08 2021-08-10 福建康鸿生物科技有限公司 一种发酵培养基及由发酵培养基制备莫匹罗星的方法
EP4273256A1 (en) 2021-02-07 2023-11-08 Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. Fermentation method for mupirocin

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1643240A1 (de) 1966-09-16 1971-06-24 Boehringer Sohn Ingelheim Verfahren zur Herstellung neuer racemischer oder optisch aktiver 1-Phenoxy-2-aminoalkane
US3977943A (en) 1971-06-12 1976-08-31 Beecham Group Limited Antibiotics
US4071536A (en) 1971-06-12 1978-01-31 Beecham Group Limited Antibiotics
GB1395907A (en) 1971-06-12 1975-05-29 Beecham Group Ltd Antibiotics
JPS5270083A (en) * 1975-12-04 1977-06-10 Yoshitomi Pharmaceut Ind Ltd Manufacture of an antibiotics, trans-pseudomonic acid
GB1577730A (en) 1976-10-23 1980-10-29 Beecham Group Ltd Treatment of infections with pseudomonicacid salts or esters thereof
GB1577545A (en) 1977-07-27 1980-10-22 Beecham Group Ltd Treatment of swine dysenter
CA1103264A (en) 1977-09-30 1981-06-16 Norman H. Rogers Purification of pseudomonic acid
CA1115699A (en) 1978-05-20 1982-01-05 Alan D. Curzons Lithium pseudomonate and its preparation
CA1196284A (en) 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
GB8415579D0 (en) 1984-06-19 1984-07-25 Beecham Group Plc Compounds
GB8428952D0 (en) 1984-11-16 1984-12-27 Beecham Group Plc Formulations
GB8530796D0 (en) 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
IE59628B1 (en) 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
IN171883B (xx) 1990-07-27 1993-01-30 Hoechst India
US5594026A (en) 1990-12-11 1997-01-14 Smithkline Beecham Group P.L.C. Polymorphs of crystalline mupirocin
US5292892A (en) 1991-05-07 1994-03-08 Sankyo Company, Limited Anti-bacterial compound and pharmaceutical compositions thereof
US6503881B2 (en) 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
AU724070B2 (en) 1996-10-01 2000-09-14 Smithkline Beecham Corporation Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
CN1345377A (zh) 1999-02-03 2002-04-17 拜奥盖尔药厂有限公司 从含假单胞菌酸复合体的培养液中分离假单胞菌酸a的方法
CZ20012724A3 (cs) 1999-02-03 2001-12-12 Biogal Gyogyszergyar Rt Způsob přípravy antibiotické pseudomonové kyseliny A mikrobiologickou cestou
US6335023B1 (en) 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use
US6528086B2 (en) 1999-09-28 2003-03-04 Zars, Inc. Methods and apparatus for drug delivery involving phase changing formulations
IL137363A (en) 2000-07-18 2005-12-18 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
IL150907A (en) 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate

Also Published As

Publication number Publication date
IS6028A (is) 2001-07-31
US6509177B1 (en) 2003-01-21
BG105776A (en) 2002-05-31
YU55601A (sh) 2003-02-28
US7078223B2 (en) 2006-07-18
PL358615A1 (en) 2004-08-09
BR0009179A (pt) 2001-11-27
SK10892001A3 (sk) 2002-06-04
IL144679A (en) 2007-06-17
US20030100083A1 (en) 2003-05-29
NO20013791D0 (no) 2001-08-02
CN1670217A (zh) 2005-09-21
EP1151131A1 (en) 2001-11-07
CZ20012724A3 (cs) 2001-12-12
AU2980800A (en) 2000-08-25
CN1203184C (zh) 2005-05-25
JP2003515311A (ja) 2003-05-07
KR20010113674A (ko) 2001-12-28
HK1041903A1 (zh) 2002-07-26
MXPA01007806A (es) 2003-06-04
US6506591B2 (en) 2003-01-14
WO2000046389A1 (en) 2000-08-10
WO2000046389A9 (en) 2001-09-07
CA2360865A1 (en) 2000-08-10
NO20013791L (no) 2001-10-02
HRP20010576A2 (en) 2002-08-31
HUP0300363A2 (hu) 2004-06-28
US20020042103A1 (en) 2002-04-11
EP1151131A4 (en) 2004-05-12
CN1354798A (zh) 2002-06-19
AU762768B2 (en) 2003-07-03
TR200102234T2 (tr) 2002-10-21

Similar Documents

Publication Publication Date Title
IL143421A0 (en) Method for culturing algae
AU7902501A (en) Fermentation process for epothilones
AU6018500A (en) Process for producing target substance by fermentation
AU6487600A (en) Process for production of an etheralcohol
AU5707000A (en) Process for producing l-amino acid
HU9902352D0 (en) Process for producing pravastatin by microbiological way
IL144679A0 (en) Process for the preparation of pseudomonic acid a antibiotic by microbiological method
AU5707300A (en) Process for producing l-amino acid
AU5884700A (en) Process for making amine compounds
AU2001227086A1 (en) Process for preparing 2-hydroxy-4-methylthiobutanoic acid
IL144678A0 (en) Process for the isolation of pseudomonic acid a from pseudomonic acid complex-containing culture broth
AU2324000A (en) Process for producing 2-hydroxy-4-methyl-thiobutanoic acid
HK1047739A1 (en) Process for phenylacetic acid derivatives
HK1047093A1 (en) Process for production of naphthyridine-3-carboxyrlic acid derivatives.
AU6018300A (en) Process for producing target substance by fermentation method
AU3843900A (en) Microbiological production method for alpha-l-aspartyl-l-phenylalanine
MX225445B (es) Metodo y produccion de n-fosfonometilglicina.
AU5571100A (en) Process for producing l-amino acid
AU5707100A (en) Process for producing l-amino acid
AU6524200A (en) Process for purifying polycarboxylic acids
AU3299900A (en) Method for the production of aliphatic fluoroformates
AUPP950399A0 (en) An improved method for forming structural articles
AU6031300A (en) Method for supervision of parallel processes
AU4277001A (en) Process for producing l-amino acid via fermentation method
AU5707200A (en) Process for producing l-amino acid

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed